Trial Profile
Ledipasvir-sofosbuvir (LDV/SOF) and proton pump inhibitor (PPI) in patients with chronic hepatitis C virus (HCV) infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Feb 2017 New trial record